NCBI . NLM . NIH . GOV {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Ncbi.nlm.nih.gov Make Money
Keywords
Topics
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC8672712/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC8672712/. The analysis below is for the second page.

Title[redir]:
Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A - PMC
Description:
The goal of gene therapy for patients with hemophilia A is to safely impart long-term stable factor VIII expression that predictably ameliorates bleeding with the use of the lowest possible vector dose. In this phase 1–2 trial, we infused an ...

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 6,398,976 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We see no obvious way the site makes money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Ncbi.nlm.nih.gov could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

factor, viii, participants, expression, vector, hemophilia, gene, activity, spk, administration, google, scholar, immune, response, doi, aav, pubmed, bleeding, events, trial, normal, data, pmc, therapy, weeks, article, kilogram, range, received, glucocorticoids, capsid, participant, safety, assay, free, transfer, year, med, efficacy, results, adverse, onestage, annualized, infusion, smf, dose, event, rate, fig, determined,

Topics {✒️}

b-domain–deleted form aav5-hfviii-sq gene therapy glucocorticoid-sparing immune-modulating agents hepatocyte-derived factor viii aav5-hfviii-sq differs plasma-derived factor viii highest-dose cohort showed liver-directed gene transfer aav-mediated gene transfer pmc beta search protein-engineered coagulation factors aav-mediated gene therapy cross-reacting material supplementary materials included pmc copyright notice aav5-hfviii-sq peripheral-blood mononuclear cells baculovirus vector-production system time disease-altering therapy aav-factor ix recombinant-aav vector consisting durable hepatocyte expression coagulation factor viii 4-year long-term follow plasma factor viii factor ix consumption ehl extended half-life drug-related adverse events mediated gene transfer factor viii activity lowest-dose cohort received factor viii function bioengineered capsid derived immune-modulating agents aav5-hfviii-sq7 factor viii expression vector-dose dependent factor viii product factor viii infusions recombinant factor viii factor viii padua glucocorticoid-sparing agents supplementary methods section [google scholar] 12 [google scholar] 20 [google scholar] 23 recurrent joint hemorrhage durable therapeutic efficacy stable fix expression aav gene transfer

Social Networks {👍}(6)

External Links {🔗}(82)

Analytics and Tracking {📊}

Google Analytics
Google Analytics 4
Google Tag Manager

Libraries {📚}

jQuery
jQuery module (jquery-3.6.0)

Emails and Hosting {✉️}

Mail Servers:

nihcesxway.hub.nih.gov
nihcesxway2.hub.nih.gov
nihcesxway3.hub.nih.gov
nihcesxway4.hub.nih.gov
nihcesxway5.hub.nih.gov

Name Servers:

dns1-ncbi.ncbi.nlm.nih.gov
dns2-ncbi.ncbi.nlm.nih.gov
lhcns1.nlm.nih.gov
lhcns2.nlm.nih.gov

CDN Services {📦}

Ncbi

3.49s.